News

Research Rate Change FY26

To All UCSF Principal Investigators:The following is an important announcement about charges for clinical research-related activities at UCSF:

Important Reminder: Submitting Amendments to OCTA

Important Reminder: Submitting Amendments to OCTA

2025 OCTA Customer Experience Survey

2025 OCTA Customer Experience Survey UCSF’s Office of Clinical Trial Activation (OCTA) is conducting a survey about your experience working with OCTA.  Your opinion is very important. We hope you will take a few minutes to share your feedback via the link sent to you in an email.…

Update to iRIS to OnCore Integration

An update to the iRIS to OnCore integration live June 25, 2025 What is changing?

Important Reminders: Ensure Complete OCTA Submissions and Correct ICF Language Prior to IRB Approvals

Avoid delays in study activation by ensuring that all required documents are submitted to the Office of Clinical Trial Activation and that your Informed Consent Form language aligns with the final budget and coverage analysis.

Updated Clinical Trial Budgeting Tools Now Available on OCTA’s Website

OCTA has updated its Clinical Trial Budgeting Tools to better support study teams when OCTA is not preparing the full study budget—such as for non-profit studies, grant-funded studies, financial feasibility, or budgets developed by the study department.  

Updates to OnCore Guides!

We’re pleased to announce that three updated OnCore Guides are now available on our website:

Study Teams Can Now Request Strategic Activation Manager Support through OCTA

We are excited to announce that the Office of Clinical Trial Activation (OCTA) now offers study teams the opportunity to request Strategic Activation Manager (SAM) support for industry trials. This service is only provided for new, industry sponsored, interventional trials that are utilizing…